<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TechBuzz &#187; lmc</title>
	<atom:link href="http://techbuzz.boranessa.com/tag/lmc/feed/" rel="self" type="application/rss+xml" />
	<link>http://techbuzz.boranessa.com</link>
	<description>Todos os zunzun&#039;s da Tecnologia</description>
	<lastBuildDate>Thu, 21 Apr 2011 09:57:42 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Cancro fatal passa a condição crónica</title>
		<link>http://techbuzz.boranessa.com/2009/11/cancro-fatal-passa-condicao-cronica/</link>
		<comments>http://techbuzz.boranessa.com/2009/11/cancro-fatal-passa-condicao-cronica/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 12:09:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Internet]]></category>
		<category><![CDATA[Saúde]]></category>
		<category><![CDATA[cancro]]></category>
		<category><![CDATA[crónica]]></category>
		<category><![CDATA[lasker]]></category>
		<category><![CDATA[leucemina]]></category>
		<category><![CDATA[lmc]]></category>
		<category><![CDATA[Mielóide]]></category>

		<guid isPermaLink="false">http://techbuzz.boranessa.com/?p=563</guid>
		<description><![CDATA[A Fundação Lasker atribuiu o prémio científico Lasker-DeBakey 2009 a três cientistas que desenvolveram novos tratamentos para a Leucemia Mielóide Crónica (LMC). Brian Druker, Nicholas Lydon e Charles Sawyers foram os investigadores responsáveis pelo Imatinib, uma molécula-dirigida para o tratamento da LMC, convertendo um cancro fatal numa condição crónica controlável. Leia o Original]]></description>
			<content:encoded><![CDATA[<p><img class="alignleft size-thumbnail wp-image-618" style="margin: 12px;" title="leucemia" src="http://techbuzz.boranessa.com/wp-content/uploads/2009/11/leucemia-150x150.jpg" alt="leucemia" width="150" height="150" /></p>
<p>A Fundação Lasker atribuiu o prémio científico Lasker-DeBakey 2009 a três cientistas que desenvolveram novos tratamentos para a Leucemia Mielóide Crónica (LMC).</p>
<p>Brian Druker, Nicholas Lydon e Charles Sawyers foram os investigadores responsáveis pelo Imatinib, uma molécula-dirigida para o tratamento da LMC, convertendo um cancro fatal numa condição crónica controlável.</p>
<p><a href="http://www.cienciahoje.pt/index.php?oid=36777&amp;op=all"> Leia o Original </a></p>
<div class="al2fb_like_button"><div id="fb-root"></div><script src="http://connect.facebook.net/pt_PT/all.js#appId=202513463112381&amp;xfbml=1" type="text/javascript"></script>
<fb:like href="http://techbuzz.boranessa.com/2009/11/cancro-fatal-passa-condicao-cronica/" layout="standard" show_faces="true" width="450" action="like" font="arial" colorscheme="light" ref="AL2FB"></fb:like></div>]]></content:encoded>
			<wfw:commentRss>http://techbuzz.boranessa.com/2009/11/cancro-fatal-passa-condicao-cronica/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

